Open an account

Nano-X Imaging

NNOX · NASDAQ

$0.3725−$0.011 (−2.87%)TodayMarket closed ·
Prev close $0.3835

About NNOX

Nano-X Imaging Ltd. engages in the development of medical imaging systems. The company is headquartered in Petah Tikva, Central(Hamerkaz) and currently employs 197 full-time employees. The company went IPO on 2020-08-21.

Employees
197
Headquarters
Petah Tikva, Central(HaMerkaz)
Listed
Aug 21, 2020
Sector
Health Care
Industry
Health Care Providers & Services
Website
nanox.vision

NNOX key statistics

Market cap
30.14M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
911.52K
Volume
549.14K
Open price
$0.3835
High today
$0.39
Low today
$0.3675
52 Week high
$4.71
52 Week low
$0.36

Nano-X Imaging (NNOX) at a glance

Nano-X Imaging (NNOX) last traded at $0.3725, with a market cap of 30.14M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.3675 and $0.39. The current price is 1.4% above the day's low and 4.5% below its high.

Volume so far is 549.14K shares, below the average of 911.52K shares a day.

Over the past year Nano-X Imaging has ranged from $0.36 to $4.71, and now sits 0% of the way up that range.

Nano-X Imaging met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.80 per share against an estimate of -$0.1666.

The average analyst price target is $4.22, 1031.8% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

67%of 3 analyst ratings say Buy
  • Buy66.7%
  • Hold33.3%
  • Sell0.0%
Price target · 5 analystsAvg $4.22
Low
$3.03
Now
$0.3725
High
$5.25

NNOX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 9.5% on average.

  1. Q3 FY24: reported -$0.15 per share against an estimate of -$0.221
  2. Q4 FY24: reported -$0.23 per share against an estimate of -$0.2312
  3. Q1 FY25: reported -$0.21 per share against an estimate of -$0.1964
  4. Q2 FY25: reported -$0.23 per share against an estimate of -$0.1938
  5. Q3 FY25: reported -$0.21 per share against an estimate of -$0.2176
  6. Q4 FY25: reported -$0.50 per share against an estimate of -$0.1964
  7. Q1 FY26: reported -$0.20 per share against an estimate of -$0.204
  8. Q2 FY26: reported -$0.80 per share against an estimate of -$0.1666

NNOX news

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Full Transcript: Nano X Imaging Q2 2026 Earnings Call

  • Press releasePRNewswire

    NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

  • Press releaseBusiness Wire

    CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

  • Press releasePRNewswire

    Urgent Deadline for Shareholders who lost money in shares of Nano-X Imaging Ltd. (NASDAQ: NNOX)

  • Press releasePRNewswire

    NNOX EQUITY ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

  • Press releasePRNewswire

    Nano-X Deadline: NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit

  • Press releaseGlobe Newswire

    NANO-X CLASS ACTION DEADLINE AUGUST 11th: Bragar Eagel & Squire, P.C. Urges Nano-X Imaging Ltd. Investors to Contact the Firm Regarding Their Rights

Similar companies

Companies in the same industry as Nano-X Imaging

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.